IP Library Granted Patent US 8,115,009
Granted Patent B2
US 8,115,009 · App. 13/004,373 · Granted Feb 14, 2012

UV-absorbers for ophthalmic lens materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,115,009
App. No.
13/004,373
Granted
Feb 14, 2012
Kind
B2
Abstract

1,4-disubstituted-1,2,3-triazole UV absorbing monomers are disclosed. The UV absorbers are particularly suitable for use in intraocular lens materials.

Claims (11)

1. A 1,4-disubstituted-1,2,3-triazole compound of the formula

where in formula [3]

R 5 is CH 2 ═CH—, CH 2 ═C(CH 3 )—, or

R 6 is H, F, Cl, Br, I, O(CH 2 ) x H, NH 2 , NH(CH 3 ), N(CH 3 ) 2 , CH 3 , CH 2 CH 3 , CH(CH 3 ) 2 , C(CH 3 ) 3 ,

C 6 H 5 , or OC 6 H 5 ;

x is 0-12;

Y is H, CH 3 , or CH 3 CH 2 ;

Z is O, NH, N(CH 3 ), N(CH 2 CH 3 ), or nothing; and

Z′ is O, NH, N(CH 3 ), N(CH 2 CH 3 ), or nothing;

provided that if x is 0, then Z≠nothing and Z′=nothing.

2. An intraocular lens comprising the 1,4-disubstituted-1,2,3-triazole compound of claim 1 .

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →